Partnering to Speed:?Transformational
Medicines to Patients
Combining passion, science and experience to deliver innovation together.
Why Partner With Us
With a long history of successful scientific and commercial collaborations that exhibit speed, collaboration, innovation, and strong partner relationships, research and development (R&D) is at the center of our strategy. With 41 compounds in development, a network of research facilities around the globe, and an annual R&D investment of $4.8 billion*,? we’ve been recognized as one of the premier R&D organizations in the industry.
*This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items.?
What We're Focused On
Working to #HackCancer
Contact us about partnering
Start the partnership process. Please send NON-CONFIDENTIAL information about your opportunity to one of the individuals below based on your area of interest:
Hematology & Cell Therapy: BD-HemaCT@bms.com
Neuroscience & CV: BD-NeuroCV@bms.com
Fibrosis & Immunology: BD-FibImm@bms.com
PDx and Biomarker: BD-PDxBiomarkers@bms.com
Research and Enabling Transactions:?BD-RET@bms.com
Digital Health Initiatives: BD-DHI@bms.com
Corporate Development: BD-CorpDev@bms.com